Target intelligence / Profile preview

Type III secretion needle tip protein PcrV (PcrV)

Target
PcrV
Molecular classification
Other (Type III secretion system component), Bacterial virulence factor, Translocation apparatus protein
01

Overview

Type III secretion needle tip protein PcrV is a hydrophilic protein located at the tip of the type III secretion system (T3SS) needle in *Pseudomonas aeruginosa*[2][3][5]. It is an essential component of the translocation apparatus, connecting the secretion needle to the host cell membrane and forming a scaffold for the correct insertion of translocator proteins PopB and PopD, which together create a pore through which effector toxins are injected into host cells[2][5][7]. PcrV is indispensable for T3SS function and pathogen virulence, and it also has a proinflammatory role, activating M1 macrophages and reducing biofilm burden during infection[1]. Anti-PcrV monoclonal antibodies and PcrV-based vaccines block pore formation and toxin injection, making PcrV a validated therapeutic target for passive and active immunotherapies designed to combat acute and chronic *P. aeruginosa* infections[1][3][5].

Other names
V-antigen (in the context of Pseudomonas aeruginosa)PcrV protein
02

Mechanism of action

Blockade of toxin injection via T3SS inhibition (antibody-mediated); Induction of host immune responses (vaccine-mediated); Inhibition of translocon formation

03

Biological functions

Mediates effector protein translocationFacilitates biofilm eradication via immune activationScaffold for translocon assemblySenses host cell contact for effector release
04

Disease associations

Infection (specifically *Pseudomonas aeruginosa* infections)Inflammation (due to proinflammatory activity)
05

Safety considerations

Potential impact on normal host-microbe interactions when targeting T3SSImmune hypersensitivity (theoretical for antibody/vaccine therapies)No major safety signals reported in available therapeutic studies
06

Interacting drugs

Humanized monoclonal antibodies (e.g., anti-PcrV antibodies)

1 more in the full profile.

07

Biomarkers

Anti-PcrV antibody titers (as indicator of immune response)PcrV expression (in research/clinical infection monitoring)

Beyond the preview

Go deeper on Type III secretion needle tip protein PcrV (PcrV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type III secretion needle tip protein PcrV (PcrV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call